Citations (56)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Katy O. Goyak, Satinder S. Sarang, A. Franzen, Susan J. Borghoff & Jessica P. Ryman-Rasmussen. (2022) Adverse outcome pathway (AOP): α2u-globulin nephropathy and kidney tumors in male rats. Critical Reviews in Toxicology 52:5, pages 345-357.
Read now
Read now
Susan P. Felter, Virunya S. Bhat, Philip A. Botham, David A. Bussard, Warren Casey, A. Wallace Hayes, Gina M. Hilton, Kelly A. Magurany, Ursula G. Sauer & Edward V. Ohanian. (2021) Assessing chemical carcinogenicity: hazard identification, classification, and risk assessment. Insight from a Toxicology Forum state-of-the-science workshop. Critical Reviews in Toxicology 51:8, pages 653-694.
Read now
Read now
Hedwig M. Braakhuis, Wout Slob, Evelyn D. Olthof, Gerrit Wolterink, Edwin P. Zwart, Eric R. Gremmer, Emiel Rorije, Jan van Benthem, Ruud Woutersen, Jan Willem van der Laan & Mirjam Luijten. (2018) Is current risk assessment of non-genotoxic carcinogens protective?. Critical Reviews in Toxicology 48:6, pages 500-511.
Read now
Read now
Lynne T. Haber, Michael L. Dourson, Bruce C. Allen, Richard C. Hertzberg, Ann Parker, Melissa J. Vincent, Andrew Maier & Alan R. Boobis. (2018) Benchmark dose (BMD) modeling: current practice, issues, and challenges. Critical Reviews in Toxicology 48:5, pages 387-415.
Read now
Read now
Margaret E. Coleman, Harry M. Marks, Richard C. Hertzberg & Michele M. Stephenson. (2017) Mechanistic modeling of salmonellosis: Update and future directions. Human and Ecological Risk Assessment: An International Journal 23:8, pages 1830-1856.
Read now
Read now
Angelo Moretto, Ammie Bachman, Alan Boobis, Keith R. Solomon, Timothy P. Pastoor, Martin F. Wilks & Michelle R. Embry. (2017) A framework for cumulative risk assessment in the 21st century. Critical Reviews in Toxicology 47:2, pages 85-97.
Read now
Read now
Keith R. Solomon, Martin F. Wilks, Ammie Bachman, Alan Boobis, Angelo Moretto, Timothy P. Pastoor, Richard Phillips & Michelle R. Embry. (2016) Problem formulation for risk assessment of combined exposures to chemicals and other stressors in humans. Critical Reviews in Toxicology 46:10, pages 835-844.
Read now
Read now
Antone L. Brooks, David G. Hoel & R. Julian Preston. (2016) The role of dose rate in radiation cancer risk: evaluating the effect of dose rate at the molecular, cellular and tissue levels using key events in critical pathways following exposure to low LET radiation. International Journal of Radiation Biology 92:8, pages 405-426.
Read now
Read now
Michelle R. Embry, Ammie N. Bachman, David R. Bell, Alan R. Boobis, Samuel M. Cohen, Michael Dellarco, Ian C. Dewhurst, Nancy G. Doerrer, Ronald N. Hines, Angelo Moretto, Timothy P. Pastoor, Richard D. Phillips, J. Craig Rowlands, Jennifer Y. Tanir, Douglas C. Wolf & John E. Doe. (2014) Risk assessment in the 21st century: Roadmap and matrix. Critical Reviews in Toxicology 44:sup3, pages 6-16.
Read now
Read now
Timothy P. Pastoor, Ammie N. Bachman, David R. Bell, Samuel M. Cohen, Michael Dellarco, Ian C. Dewhurst, John E. Doe, Nancy G. Doerrer, Michelle R. Embry, Ronald N. Hines, Angelo Moretto, Richard D. Phillips, J. Craig Rowlands, Jennifer Y. Tanir, Douglas C. Wolf & Alan R. Boobis. (2014) A 21st century roadmap for human health risk assessment. Critical Reviews in Toxicology 44:sup3, pages 1-5.
Read now
Read now
Articles from other publishers (46)
Gina M. Hilton, Yadvinder Bhuller, John E. Doe, Douglas C. Wolf & Richard A. Currie. (2023) A new paradigm for regulatory sciences. Regulatory Toxicology and Pharmacology 145, pages 105524.
Crossref
Crossref
Yun Zhou, Qiran Chen, James E Klaunig & Kan Shao. (2023) A mode of action-based probabilistic framework of dose-response assessment for nonmutagenic liver carcinogens: a case study of PCB-126. Toxicological Sciences 196:2, pages 250-260.
Crossref
Crossref
David O Onyango, Bastian G Selman, Jane L Rose, Corie A Ellison & J F Nash. (2023) Comparison between endocrine activity assessed using ToxCast/Tox21 database and human plasma concentration of sunscreen active ingredients/UV filters. Toxicological Sciences 196:1, pages 25-37.
Crossref
Crossref
Mark Lafranconi, Janet Anderson, Robert Budinsky, Lisa Corey, Norman Forsberg, Joanna Klapacz & Matthew J. LeBaron. (2023) An integrated assessment of the 1,4-dioxane cancer mode of action and threshold response in rodents. Regulatory Toxicology and Pharmacology 142, pages 105428.
Crossref
Crossref
George Wypych. 2023. Handbook of Plasticizers. Handbook of Plasticizers
693
752
.
Makoto Hayashi. (2022) Opinion: regulatory genotoxicity: past, present and future. Genes and Environment 44:1.
Crossref
Crossref
C.R. Kirman, C.M. North, N.Y. Tretyakova, N. Erraguntla, H. Shen & S.M. Hays. (2022) Use of biomarker data and metabolite relative potencies to support derivation of noncancer reference values based on the reproductive and developmental toxicity effects of 1,3-butadiene. Regulatory Toxicology and Pharmacology 134, pages 105239.
Crossref
Crossref
Gina M. Hilton, Catherine Adcock, Gregory Akerman, James Baldassari, Michael Battalora, Warren Casey, Amy J. Clippinger, Rhian Cope, Amber Goetz, A. Wallace Hayes, Sabitha Papineni, Richard C. Peffer, Deborah Ramsingh, Brandy Williamson Riffle, Mitscheli Sanches da Rocha, Natalia Ryan, Edward Scollon, Nicolo Visconti, Douglas C. Wolf, Zhongyu Yan & Anna Lowit. (2022) Rethinking chronic toxicity and carcinogenicity assessment for agrochemicals project (ReCAAP): A reporting framework to support a weight of evidence safety assessment without long-term rodent bioassays. Regulatory Toxicology and Pharmacology 131, pages 105160.
Crossref
Crossref
Maykel Hernández-Mesa, Luca Narduzzi, Sadia Ouzia, Nicolas Soetart, Laetitia Jaillardon, Yann Guitton, Bruno Le Bizec & Gaud Dervilly. (2022) Metabolomics and lipidomics to identify biomarkers of effect related to exposure to non-dioxin-like polychlorinated biphenyls in pigs. Chemosphere 296, pages 133957.
Crossref
Crossref
John Rooney, Leah C. Wehmas, Natalia Ryan, Brian N. Chorley, Susan D. Hester, Elaina M. Kenyon, Judith E. Schmid, Barbara Jane George, Michael F. Hughes, Yusupha M. Sey, Alan H. Tennant, Jane Ellen Simmons, Charles E. Wood & J. Christopher Corton. (2022) Genomic comparisons between hepatocarcinogenic and non-hepatocarcinogenic organophosphate insecticides in the mouse liver. Toxicology 465, pages 153046.
Crossref
Crossref
M. Hernández-Mesa, B. Le Bizec & G. Dervilly. (2021) Metabolomics in chemical risk analysis – A review. Analytica Chimica Acta 1154, pages 338298.
Crossref
Crossref
Mark Lafranconi, Robert Budinsky, Lisa Corey, Joanna Klapacz, James Crissman, Matthew LeBaron, Rachel Golden & Richard Pleus. (2021) A 90-day drinking water study in mice to characterize early events in the cancer mode of action of 1,4-dioxane. Regulatory Toxicology and Pharmacology 119, pages 104819.
Crossref
Crossref
Joanna Klapacz & B. Bhaskar Gollapudi. (2019) Considerations for the Use of Mutation as a Regulatory Endpoint in Risk Assessment. Environmental and Molecular Mutagenesis 61:1, pages 84-93.
Crossref
Crossref
Samuel M. Cohen, Alan R. Boobis, Vicki L. Dellarco, John E. Doe, Penelope A. Fenner-Crisp, Angelo Moretto, Timothy P. Pastoor, Rita S. Schoeny, Jennifer G. Seed & Douglas C. Wolf. (2019) Chemical carcinogenicity revisited 3: Risk assessment of carcinogenic potential based on the current state of knowledge of carcinogenesis in humans. Regulatory Toxicology and Pharmacology 103, pages 100-105.
Crossref
Crossref
Magdalena Gajęcka, Agnieszka Waśkiewicz, Łukasz Zielonka, Piotr Goliński, Anna Rykaczewska, Sylwia Lisieska-Żołnierczyk & Maciej T. Gajęcki. (2018) Mycotoxin levels in the digestive tissues of immature gilts exposed to zearalenone and deoxynivalenol. Toxicon 153, pages 1-11.
Crossref
Crossref
Salomon Sand, Roland Lindqvist, Dietrich von Rosen & Nils-Gunnar Ilbäck. (2018) Dose-Related Severity Sequence, and Risk-Based Integration, of Chemically Induced Health Effects. Toxicological Sciences 165:1, pages 74-89.
Crossref
Crossref
Andrew G. Smith & John R. Foster. (2018) The association between chemical-induced porphyria and hepatic cancer. Toxicology Research 7:4, pages 647-663.
Crossref
Crossref
Andreas Zeller, Stefan Pfuhler, Silvio Albertini, Frank Bringezu, Andreas Czich, Yasmin Dietz, Rolf Fautz, Nicola J Hewitt, Annette Kirst & Peter Kasper. (2018) A critical appraisal of the sensitivity of in vivo genotoxicity assays in detecting human carcinogens. Mutagenesis 33:2, pages 179-193.
Crossref
Crossref
Leah C Wehmas, Charles E Wood, Remi Gagne, Andrew Williams, Carole Yauk, Mark M Gosink, Deidre Dalmas, Ruixin Hao, Raegan O’Lone & Susan Hester. (2018) Demodifying RNA for Transcriptomic Analyses of Archival Formalin-Fixed Paraffin-Embedded Samples. Toxicological Sciences 162:2, pages 535-547.
Crossref
Crossref
L.R. Rhomberg, T.A. Lewandowski, D.M. Pizzurro & J.E. Goodman. 2018. Comprehensive Toxicology. Comprehensive Toxicology
473
488
.
Sabrina Wilde, Miriam Dambowsky, Claudia Hempt, Andreas Sutter & Nina Queisser. (2017) Classification of in vitro genotoxicants using a novel multiplexed biomarker assay compared to the flow cytometric micronucleus test. Environmental and Molecular Mutagenesis 58:9, pages 662-677.
Crossref
Crossref
Patience Browne, Pamela D. Noyes, Warren M. Casey & David J. Dix. (2017) Application of Adverse Outcome Pathways to U.S. EPA’s Endocrine Disruptor Screening Program. Environmental Health Perspectives 125:9.
Crossref
Crossref
Kerry L. Dearfield, B. Bhaskar Gollapudi, Jeffrey C. Bemis, R. Daniel Benz, George R. Douglas, Rosalie K. Elespuru, George E. Johnson, David J. Kirkland, Matthew J. LeBaron, Albert P. Li, Francesco Marchetti, Lynn H. Pottenger, Emiel Rorije, Jennifer Y. Tanir, Veronique Thybaud, Jan van Benthem, Carole L. Yauk, Errol Zeiger & Mirjam Luijten. (2016) Next generation testing strategy for assessment of genomic damage: A conceptual framework and considerations. Environmental and Molecular Mutagenesis 58:5, pages 264-283.
Crossref
Crossref
Thomas Colnot & Wolfgang Dekant. (2017) Approaches for grouping of pesticides into cumulative assessment groups for risk assessment of pesticide residues in food. Regulatory Toxicology and Pharmacology 83, pages 89-99.
Crossref
Crossref
Jessica L. LaRocca, Reza J. Rasoulpour, B. Bhaskar Gollapudi, David L. Eisenbrandt, Lynea A. Murphy & Matthew J. LeBaron. (2017) Integration of novel approaches demonstrates simultaneous metabolic inactivation and CAR-mediated hepatocarcinogenesis of a nitrification inhibitor. Toxicology Reports 4, pages 586-597.
Crossref
Crossref
Magdalena Gajęcka, Łukasz Zielonka & Maciej Gajęcki. (2016) Activity of Zearalenone in the Porcine Intestinal Tract. Molecules 22:1, pages 18.
Crossref
Crossref
Tina Bahadori, David Bell, Sandra Ceccatelli, Raffaella Corvi, Christer Hogstrand, Sharon Munn, Eric Nilsson, David Spurgeon, Jochen Vom Brocke, Diane Wray‐Cahen, Matt Wright, Marco Binaglia, Jean‐Lou Dorne, Nikolaos Georgiadis, Andrea Germini, George Kass, Tobin Robinson, Annamaria Rossi, Reinhilde Schoonjans, Andrea Terron & Hubert Noteborn. (2016) EFSA Scientific Colloquium 22 – Epigenetics and Risk Assessment: Where do we stand?. EFSA Supporting Publications 13:12.
Crossref
Crossref
Susan D. Hester, Virunya Bhat, Brian N. Chorley, Gleta Carswell, Wendell Jones, Leah C. Wehmas & Charles E. Wood. (2016) Editor’s Highlight: Dose–Response Analysis of RNA-Seq Profiles in Archival Formalin-Fixed Paraffin-Embedded Samples. Toxicological Sciences 154:2, pages 202-213.
Crossref
Crossref
Alan R. Boobis, Samuel M. Cohen, Vicki L. Dellarco, John E. Doe, Penelope A. Fenner-Crisp, Angelo Moretto, Timothy P. Pastoor, Rita S. Schoeny, Jennifer G. Seed & Douglas C. Wolf. (2016) Classification schemes for carcinogenicity based on hazard-identification have become outmoded and serve neither science nor society. Regulatory Toxicology and Pharmacology 82, pages 158-166.
Crossref
Crossref
Marcus D. Wilson, Samir Benlekbir, Amélie Fradet-Turcotte, Alana Sherker, Jean-Philippe Julien, Andrea McEwan, Sylvie M. Noordermeer, Frank Sicheri, John L. Rubinstein & Daniel Durocher. (2016) The structural basis of modified nucleosome recognition by 53BP1. Nature 536:7614, pages 100-103.
Crossref
Crossref
Penelope A. Fenner-Crisp & Vicki L. Dellarco. (2016) Key Elements for Judging the Quality of a Risk Assessment. Environmental Health Perspectives 124:8, pages 1127-1135.
Crossref
Crossref
Russell S. Thomas & Michael D. Waters. 2016. Toxicogenomics in Predictive Carcinogenicity. Toxicogenomics in Predictive Carcinogenicity
154
184
.
Louis Anthony (Tony) Cox, Douglas A. Popken, A. Michael Kaplan, Laura M. Plunkett & Richard A. Becker. (2016) How well can in vitro data predict in vivo effects of chemicals? Rodent carcinogenicity as a case study. Regulatory Toxicology and Pharmacology 77, pages 54-64.
Crossref
Crossref
Magdalena Gajęcka, Piotr Sławuta, Jakub Nicpoń, Roman Kołacz, Zdzisław Kiełbowicz, Łukasz Zielonka, Michał Dąbrowski, Wojciech Szweda, Maciej Gajęcki & Józef Nicpoń. (2016) Zearalenone and its metabolites in the tissues of female wild boars exposed per os to mycotoxins. Toxicon 114, pages 1-12.
Crossref
Crossref
Bas J. Blaauboer, Alan R. Boobis, Bobbie Bradford, Andrew Cockburn, Anne Constable, Mardas Daneshian, Gareth Edwards, Jossie A. Garthoff, Brett Jeffery, Cyrille Krul & Jeroen Schuermans. (2016) Considering new methodologies in strategies for safety assessment of foods and food ingredients. Food and Chemical Toxicology 91, pages 19-35.
Crossref
Crossref
C.R. Kirman, B. Hughes, R.A. Becker & S.M. Hays. (2016) Derivation of a No-significant-risk-level (NSRL) for dermal exposures to diethanolamine. Regulatory Toxicology and Pharmacology 76, pages 137-151.
Crossref
Crossref
April D. Lake, Charles E. Wood, Virunya S. Bhat, Brian N. Chorley, Gleta K. Carswell, Yusupha M. Sey, Elaina M. Kenyon, Beth Padnos, Tanya M. Moore, Alan H. Tennant, Judith E. Schmid, Barbara Jane George, David G. Ross, Michael F. Hughes, J. Christopher Corton, Jane Ellen Simmons, Charlene A. McQueen & Susan D. Hester. (2016) Dose and Effect Thresholds for Early Key Events in a PPARα-Mediated Mode of Action. Toxicological Sciences 149:2, pages 312-325.
Crossref
Crossref
Samuel M. Cohen & Lora L. Arnold. (2016) Critical role of toxicologic pathology in a short-term screen for carcinogenicity. Journal of Toxicologic Pathology 29:4, pages 215-227.
Crossref
Crossref
Bruce A. Fowler. 2016. Molecular Biological Markers for Toxicology and Risk Assessment. Molecular Biological Markers for Toxicology and Risk Assessment
63
80
.
A. Sarrabay, C. Hilmi, H. Tinwell, F. Schorsch, M. Pallardy, R. Bars & D. Rouquié. (2015) Low dose evaluation of the antiandrogen flutamide following a Mode of Action approach. Toxicology and Applied Pharmacology 289:3, pages 515-524.
Crossref
Crossref
Richard A. Becker, Grace Patlewicz, Ted W. Simon, J. Craig Rowlands & Robert A. Budinsky. (2015) The adverse outcome pathway for rodent liver tumor promotion by sustained activation of the aryl hydrocarbon receptor. Regulatory Toxicology and Pharmacology 73:1, pages 172-190.
Crossref
Crossref
Charles E. Wood, Renee R. Hukkanen, Radhakrishna Sura, David Jacobson-Kram, Thomas Nolte, Marielle Odin & Samuel M. Cohen. (2015) Scientific and Regulatory Policy Committee (SRPC) Review*. Toxicologic Pathology 43:6, pages 760-775.
Crossref
Crossref
Ted W. Simon, Robert A. Budinsky & J. Craig Rowlands. (2015) A Model for Aryl Hydrocarbon Receptor-Activated Gene Expression Shows Potency and Efficacy Changes and Predicts Squelching Due to Competition for Transcription Co-Activators. PLOS ONE 10:6, pages e0127952.
Crossref
Crossref
James T. MacGregor, Roland Frötschl, Paul A. White, Kenny S. Crump, David A. Eastmond, Shoji Fukushima, Melanie Guérard, Makoto Hayashi, Lya G. Soeteman-Hernández, George E. Johnson, Toshio Kasamatsu, Dan D. Levy, Takeshi Morita, Lutz Müller, Rita Schoeny, Maik J. Schuler & Véronique Thybaud. (2015) IWGT report on quantitative approaches to genotoxicity risk assessment II. Use of point-of-departure (PoD) metrics in defining acceptable exposure limits and assessing human risk. Mutation Research/Genetic Toxicology and Environmental Mutagenesis 783, pages 66-78.
Crossref
Crossref
Grace Patlewicz, Ted W. Simon, J. Craig Rowlands, Robert A. Budinsky & Richard A. Becker. (2015) Proposing a scientific confidence framework to help support the application of adverse outcome pathways for regulatory purposes. Regulatory Toxicology and Pharmacology 71:3, pages 463-477.
Crossref
Crossref
Richard A. Becker, Katie Paul Friedman, Ted W. Simon, M. Sue Marty, Grace Patlewicz & J. Craig Rowlands. (2015) An exposure:activity profiling method for interpreting high-throughput screening data for estrogenic activity—Proof of concept. Regulatory Toxicology and Pharmacology 71:3, pages 398-408.
Crossref
Crossref